v3.25.1
Segment Information (Details)
$ in Thousands
 3 Months Ended
Mar. 31, 2025
USD ($)
segment
Mar. 31, 2024
USD ($)
Segment Reporting    
Product revenue, net $ 168 $ 582
Cost of goods sold 14 80
Research and development costs:    
Total research and development costs 4,554 11,401
Selling, general and administrative costs:    
Total selling, general and administrative costs 5,699 13,264
Total operating expenses 10,267 24,745
Other (income) expense    
Interest expense 3,993 3,607
Interest income (279) (947)
Other (income) expense, net (6,559) (32)
Net Income (Loss) $ (7,254) (26,791)
Number of operating segments | segment 1  
Number of reportable segments | segment 1  
Single reportable segment | Operating segments    
Segment Reporting    
Product revenue, net $ 168 582
Cost of goods sold 14 80
Research and development costs:    
Personnel and related costs 1,682 3,630
Non-cash stock-based compensation (514) 1,281
Professional fees 779 1,307
Clinical trials expense 2,018 4,068
Chemical, manufacturing and controls cost 175 549
Other expenses 414 566
Total research and development costs 4,554 11,401
Commercial costs:    
Personnel and related costs 79 1,149
Non-cash stock-based compensation   268
Professional fees 38 71
Commercial and marketing 169 1,347
Travel related expenses 9 117
Other expenses (88) 196
Total commercial costs 207 3,148
Selling, general and administrative costs:    
Personnel and related costs 993 2,037
Non-cash stock-based compensation 694 1,884
Professional fees 2,834 5,240
Travel related expenses 116 247
Other expenses 855 708
Total selling, general and administrative costs 5,492 10,116
Total operating expenses 10,267 24,745
Other (income) expense    
Interest expense 3,993 3,607
Interest income (279) (947)
Other (income) expense, net (6,559) (32)
Net Income (Loss) $ (7,254) $ (26,791)